“In 2024, I am most excited about the opportunity Insmed has to progress our treatments forward for patients. While this year will be a transformational one for us as a company, it has greater potential to be transformational to the lives of patients. It is extremely rewarding to work in the rare disease space and provide a voice for those who are often not heard. I am truly grateful for the role Insmed allows me to play as we strive to improve the lives of others and excited to see what we will achieve in 2024 and beyond.”
by